Year: 2011
Type: article
Abstract: OverviewNeuroendocrine tumors account for approximately 20% of lung cancers; most (∼ 15%) are small cell lung cancer (SCLC), which are treated using the NCCN Guidelines for SCLC.[1][2][3] In 2011, an estimated 33,000 new cases of SCLC will occur in the United States.4 Nearly all cases of SCLC are attributable to cigarette smoking.Although the incidence of SCLC has been decreasing, the incidence in women is increasing and the male-to-female incidence ratio is now 1:1. 2 Other lung neuroendocrine tumors (LNTs) are treated according to the LNT algorithm on page 1098 (see also the discussion section on page 1107).
Authors: Gregory P. Kalemkerian, Wallace Akerley, Paul Bogner, Hossein Borghaei, Laura Chow, Robert J. Downey, Leena Gandhi, Apar Kishor P. Ganti, Ramaswamy Govindan, John C. Grecula, James Hayman, Rebecca Suk Heist, Leora Horn, Thierry M. Jahan, Marianna Koczywas, Cesar A. Moran, Harvey B. Niell, Janis O'Malley, Jyoti D. Patel, Neal Ready, Charles M. Rudin, Charles C. Williams
Language: English
Topic: Lung Cancer Research Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4251398052